Cargando…
Mixed lineage kinase ZAK promotes epithelial–mesenchymal transition in cancer progression
ZAK, a mixed lineage kinase, is often described as a positive or negative regulator of cell growth. We identified it as one of the top hits in our kinome cDNA screen for potent regulators of epithelial mesenchymal transition (EMT). Ectopic expression of ZAK promoted EMT phenotypes and apoptosis resi...
Autores principales: | Li, Linna, Su, Ning, Zhou, Ting, Zheng, Dayong, Wang, Zheng, Chen, Haoyu, Yuan, Shoujun, Li, Wenliang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5833348/ https://www.ncbi.nlm.nih.gov/pubmed/29396440 http://dx.doi.org/10.1038/s41419-017-0161-x |
Ejemplares similares
-
CDKL2 promotes epithelial-mesenchymal transition and breast cancer progression
por: Li, Linna, et al.
Publicado: (2014) -
Computational and Functional Analysis of Structural Features in the ZAKα Kinase
por: Johansen, Valdemar Brimnes Ingemann, et al.
Publicado: (2023) -
Direct extraction of topological Zak phase with the synthetic dimension
por: Li, Guangzhen, et al.
Publicado: (2023) -
A Requirement for ZAK Kinase Activity in Canonical TGF-β Signaling()
por: Nyati, Shyam, et al.
Publicado: (2016) -
Small molecule kinase inhibitors block the ZAK-dependent inflammatory effects of doxorubicin
por: Wong, John, et al.
Publicado: (2013)